188 related articles for article (PubMed ID: 34010494)
1. Sleep quality and outcome of exposure therapy in adults with social anxiety disorder.
Dutcher CD; Dowd SM; Zalta AK; Taylor DJ; Rosenfield D; Perrone A; Otto MW; Pollack MH; Hofmann SG; Smits JAJ
Depress Anxiety; 2021 Nov; 38(11):1182-1190. PubMed ID: 34010494
[TBL] [Abstract][Full Text] [Related]
2. Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
Zalta AK; Dowd S; Rosenfield D; Smits JA; Otto MW; Simon NM; Meuret AE; Marques L; Hofmann SG; Pollack MH
Depress Anxiety; 2013 Nov; 30(11):1114-20. PubMed ID: 24038728
[TBL] [Abstract][Full Text] [Related]
3. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
Smits JAJ; Pollack MH; Rosenfield D; Otto MW; Dowd S; Carpenter J; Dutcher CD; Lewis EM; Witcraft SM; Papini S; Curtiss J; Andrews L; Kind S; Conroy K; Hofmann SG
JAMA Netw Open; 2020 Jun; 3(6):e206777. PubMed ID: 32496566
[TBL] [Abstract][Full Text] [Related]
4. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
[TBL] [Abstract][Full Text] [Related]
5. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
Smits JA; Rosenfield D; Otto MW; Marques L; Davis ML; Meuret AE; Simon NM; Pollack MH; Hofmann SG
J Psychiatr Res; 2013 Oct; 47(10):1455-61. PubMed ID: 23870811
[TBL] [Abstract][Full Text] [Related]
6. The enhancing effects of testosterone in exposure treatment for social anxiety disorder: a randomized proof-of-concept trial.
Hutschemaekers MHM; de Kleine RA; Hendriks GJ; Kampman M; Roelofs K
Transl Psychiatry; 2021 Aug; 11(1):432. PubMed ID: 34417443
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
8. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
[TBL] [Abstract][Full Text] [Related]
9. Effects of post-exposure naps on exposure therapy for social anxiety.
Pace-Schott EF; Bottary RM; Kim SY; Rosencrans PL; Vijayakumar S; Orr SP; Lasko NB; Goetter EM; Baker AW; Bianchi MT; Gannon K; Hoeppner SS; Hofmann SG; Simon NM
Psychiatry Res; 2018 Dec; 270():523-530. PubMed ID: 30340182
[TBL] [Abstract][Full Text] [Related]
10. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.
Smits JA; Rosenfield D; Davis ML; Julian K; Handelsman PR; Otto MW; Tuerk P; Shiekh M; Rosenfield B; Hofmann SG; Powers MB
Biol Psychiatry; 2014 Jun; 75(11):840-6. PubMed ID: 24237691
[TBL] [Abstract][Full Text] [Related]
11. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction?
Roque AD; Rosenfield D; Smits JAJ; Simon N; Otto MW; Marques L; Pollack MH; Hofmann SG; Meuret AE
J Anxiety Disord; 2018 Jan; 53():85-90. PubMed ID: 29227845
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
13. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
[TBL] [Abstract][Full Text] [Related]
14. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
[TBL] [Abstract][Full Text] [Related]
15. Sleep quality and treatment of social anxiety disorder.
Horenstein A; Morrison AS; Goldin P; Ten Brink M; Gross JJ; Heimberg RG
Anxiety Stress Coping; 2019 Jul; 32(4):387-398. PubMed ID: 31082285
[No Abstract] [Full Text] [Related]
16. Endogenous in-session cortisol during exposure therapy predicts symptom improvement: Preliminary results from a scopolamine-augmentation trial.
Kuhlman KR; Treanor M; Imbriano G; Craske MG
Psychoneuroendocrinology; 2020 Jun; 116():104657. PubMed ID: 32244170
[TBL] [Abstract][Full Text] [Related]
17. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder.
Hofmann SG; Papini S; Carpenter JK; Otto MW; Rosenfield D; Dutcher CD; Dowd S; Lewis M; Witcraft S; Pollack MH; Smits JAJ
PLoS One; 2019; 14(10):e0223729. PubMed ID: 31622374
[TBL] [Abstract][Full Text] [Related]
18. Endogenous testosterone levels are predictive of symptom reduction with exposure therapy in social anxiety disorder.
Hutschemaekers MHM; de Kleine RA; Davis ML; Kampman M; Smits JAJ; Roelofs K
Psychoneuroendocrinology; 2020 May; 115():104612. PubMed ID: 32113047
[TBL] [Abstract][Full Text] [Related]
19. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
20. Does prediction error during exposure relate to clinical outcomes in cognitive behavior therapy for social anxiety disorder? A study protocol.
Winkler CD; Koval P; Phillips LJ; Felmingham KL
Front Psychiatry; 2022; 13():1000686. PubMed ID: 37082515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
